APLM

Apolomics Inc. (APLMW)

Market Closed
4 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
NASDAQ (CM) NASDAQ (CM) Primary
$
0. 02
-0
-2.12%
$
248.3M Market Cap
- P/E Ratio
0% Div Yield
8,537 Volume
- Eps
$ 0.02
Previous Close
Day Range
0.02 0.02
Year Range
0.02 0.03
Want to track APLMW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

APLMW closed today lower at $0.02, a decrease of 2.12% from yesterday's close, completing a monthly increase of 0% or $0.02. Over the past 12 months, APLMW stock gained 0%.
APLMW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

APLMW Chart

No Data

Similar

BHSE
Bull Horn Holdings Corp.
$ 11.95
+44.67%
HUHU
Huhutech International Group Inc.
$ 9.75
+4.39%
ZJK
Zjk Industrial Co. Ltd.
$ 3.03
-8.46%
AIRJ
Airjoule Technologies Corp.
$ 2.95
-6.65%
HPAI
Helport AI Ltd.
$ 3.85
+1.58%

Apolomics Inc. (APLMW) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

Apolomics Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is APLMW.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 248.3M.

Has Apolomics Inc. ever had a stock split?

No, there has never been a stock split.

Apolomics Inc. Profile

Industrial Conglomerates Industry
Industrials Sector
Guo-Liang Yu CEO
NASDAQ (CM) Exchange
KYG0411D1152 ISIN
US Country
13 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Apollomics, Inc. is a dynamic force in the biotechnology landscape, specializing in the groundbreaking area of oncology therapy research and development. Founded in 2015 by visionaries Liang Yu Guo and Sanjeev Redkar, the company has swiftly moved to the forefront of clinical-stage biotechnology, focusing its efforts on innovating treatments for cancer. With its headquarters in Foster City, California, Apollomics is committed to fulfilling the pressing need for more effective cancer therapies, utilizing cutting-edge science to bring hope to patients facing dire diagnoses.

Products and Services

  • Oncology Therapies Development

    • At the heart of Apollomics' mission is the development of novel oncology therapies. By strategically targeting the most challenging unmet medical needs within the cancer treatment landscape, the company is dedicated to engineering innovative drugs. Their pipeline represents a beacon of hope, aiming to transform the therapeutic landscape through advances in science and medicine.

Contact Information

Address: 989 East Hillsdale Blvd
Phone: 650 209 4055
Affiliate Program About Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark